We found that NKG7, IL32, GZMA, PRF1, CST7, GZMH, and CCL5 were among the top DEG downregulated in CD3+ upon nasal Foralumab treatment of COVID-19 subjects. This evidence concerns the gene CCL5 and COVID-19.